Ammonium Acetate → HCID 178506376、化合物
反応式
O=[C:2]([C:20]1[CH:25]=[CH:24][CH:23]=[C:22]([O:26][C:27]([F:30])([F:29])[F:28])[CH:21]=1)[CH2:3][NH:4][C:5]([CH:7]1[CH2:12][CH2:11][N:10](C(OC(C)(C)C)=O)[CH2:9][CH2:8]1)=O.C([O-])(=O)C.[NH4+:35]>C(O)(=O)C>[F:28][C:27]([F:30])([F:29])[O:26][C:22]1[CH:21]=[C:20]([C:2]2[N:35]=[C:5]([CH:7]3[CH2:12][CH2:11][NH:10][CH2:9][CH2:8]3)[NH:4][CH:3]=2)[CH:25]=[CH:24][CH:23]=1参加物
4
実験手順
Add tert-butyl 4-(2-oxo-2-(3-(trifluoromethoxy)phenyl)ethylcarbamoyl)-piperidine-1-carboxylate (1.50 g, 3.48 mmol) to a mixture of ammonium acetate (1.40 g, 18.1 mmol), and glacial acetic acid (10 mL) and heat at reflux for 15 h. Cool the mixture to room temperature and concentrated in vacuo. Dissolve the residue in ethyl acetate (50 mL) and adjust to pH 8 with saturated NaHCO3. Extract the aqueous layer with ethyl acetate (2×50 mL). Combine the organic layers, dry (Na2SO4), filter, and concentrate in vacuo. Purify the residue by silica gel chromatography (80 g, eluting with a gradient of 10% to 20% methanol/ethyl acetate, 1.5 L) to provide 4-(4-(3-(trifluoromethoxy)phenyl)-1H-imidazol-2-yl)piperidine (491 mg, 45%).
後処理
- temperatureheat
- temperatureat reflux for 15 h
- concentrationconcentrated in vacuo
- dissolutionDissolve the residue in ethyl acetate (50 mL)
- extractionExtract the aqueous layer with ethyl acetate (2×50 mL)
- dry with materialCombine the organic layers, dry (Na2SO4)
- filtrationfilter
- concentrationconcentrate in vacuo
- customPurify the residue by silica gel chromatography (80 g
- washeluting with a gradient of 10% to 20% methanol/ethyl acetate, 1.5 L)
出典と根拠
- ORDレコード
- ord-ec672467612543f5990e403f1f8aded9
- 出典データセット
- uspto-grants-2012_01
- 特許番号
- US08093383B2
反応ノート
読み込み中…